One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Antithrombotic treatment: personalized antiplatelet therapies and lessons from the gut microbiota
Filippo Crea
doi : 10.1093/eurheartj/ehad521
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3023–3026
Are we ready for cell-specific therapies in atherosclerosis?
Abdul Waheed Khan
Investigator Nazha Hamdani MD, PhD, talks to CardioPulse about her love of science and why we may be closer than we think to unravelling a clinical conundrum
Judith Ozkan
Implementation of a national primary percutaneous coronary intervention program for ST-segment elevation myocardial infarction in the Kingdom of Bahrain: an inspiring success story from a centre of excellence
Haitham Amin, Husam A Noor, Fawaz Bardooli, Nooraldaem Yousif
Heart failure and socioeconomic status: global differences and inequalities
Rocco Vergallo, Carlo Patrono
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis
Bruna Gigante, Jerrold H Levy, Eric van Gorp, Alessandro Bartoloni, Marie-Luce Bochaton-Piallat, Magnus Bäck, Hugo ten Cate, Christina Christersson, José Luis Ferreiro, Tobias Geisler, Esther Lutgens, Sam Schulman, Robert F Storey, Jecko Thachil, Gemma Vilahur, Patricia C Liaw, Bianca Rocca
Personalised antiplatelet therapies for coronary artery disease: what the future holds
Davide Capodanno, Dominick J Angiolillo
Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis
Nick van Es, Toshihiko Takada, Noémie Kraaijpoel, Frederikus A Klok, Milou A M Stals, Harry R Büller, D Mark Courtney, Yonathan Freund, Javier Galipienzo, Grégoire Le Gal, Waleed Ghanima, Menno V Huisman, Jeffrey A Kline, Karel G M Moons, Sameer Parpia, Arnaud Perrier, Marc Righini, Helia Robert-Ebadi, Pierre-Marie Roy, Phil S Wells, Kerstin de Wit, Maarten van Smeden, Geert-Jan Geersing
A novel prediction model for pulmonary embolism: from dichotomizing algorithms to personalized likelihood
Thomas A Zelniker, Irene M Lang
Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality
Ina Nemet, Xinmin S Li, Arash Haghikia, Lin Li, Jennifer Wilcox, Kymberleigh A Romano, Jennifer A Buffa, Marco Witkowski, Ilja Demuth, Maximilian König, Elisabeth Steinhagen-Thiessen, Fredrik Bäckhed, Michael A Fischbach, W H Wilson Tang, Ulf Landmesser, Stanley L Hazen
A roadmap for gut microbiome-derived aromatic amino acids for improved cardiovascular risk stratification
Barbara E Stähli, Michael Scharl, Christian M Matter
Comparison of bleeding risk between standard ticagrelor and prasugrel therapies without de-escalation strategy
Selçuk Şen
Comparison of standard ticagrelor and prasugrel therapies based on previous trials
Jeehoon Kang, Kyung Woo Park, Hyo-Soo Kim
Intravenous thrombolysis for bioprosthetic valve thrombosis
Rik Adrichem, Ricardo P J Budde, Nicolas M Van Mieghem
